Takeda Pharmaceuticals America, Inc.
- A02 - Agentes para el tratamiento de alteraciones causadas por ácidos
- DEXILANT gastro-resistant capsule, hard 30 mg
- DEXILANT gastro-resistant capsule, hard 60 mg
- PREVACID gastro-resistant capsule, hard 15 mg
- PREVACID gastro-resistant capsule, hard 30 mg
- PREVACID SOLUTAB orodispersible tablet 15 mg
- PREVACID SOLUTAB orodispersible tablet 30 mg
- PREVPAC CAPSULES HARD AND FILM COATED TABLET capsule, hard 30 mg - 500 mg - 500 mg
- A06 - Agentes contra el estreñimiento
- AMITIZA capsule, soft 24 µg
- A10 - Antidiabéticos
- ACTOPLUS MET film-coated tablet 500 mg+15 mg
- ACTOPLUS MET film-coated tablet 850 mg+15 mg
- ACTOS tablet 15 mg
- ACTOS tablet 30 mg
- ACTOS tablet 45 mg
- DUETACT tablet 2 mg+30 mg
- DUETACT tablet 4 mg+30 mg
- KAZANO film-coated tablet 1 000 mg+12.5 mg
- KAZANO film-coated tablet 500 mg+12.5 mg
- C09 - Agentes activos sobre el sistema renina-angiotensina
- EDARBI tablet 40 mg
- EDARBI tablet 80 mg
- EDARBYCLOR film-coated tablet 40 mg+12.5 mg
- EDARBYCLOR film-coated tablet 40 mg+25 mg
- L04 - Inmunosupresores
- ENTYVIO powder for solution for infusion 300 mg
- M04 - Antigotosos
- ULORIC tablet 40 mg
- ULORIC tablet 80 mg
- N05 - Psicolépticos
- ROZEREM film-coated tablet 8 mg
- N06 - Psicoanalépticos
- BRINTELLIX film-coated tablet 10 mg
- BRINTELLIX film-coated tablet 15 mg
- BRINTELLIX film-coated tablet 20 mg
- BRINTELLIX film-coated tablet 5 mg